Select Page
Home 9 Holiday WishesPage 58
First Alzheimer’s Treatment by Biogen Approved by FDA
First Alzheimer’s Treatment by Biogen Approved by FDA

The U.S Food and Drug Administration (FDA) has approved Biogen’s aducanumab treatment for Alzheimer's which aims to eliminate the sticky deposits of amyloid beta found in the brains of patients in the initial stages of the disease. In spite of controversy and...

FDA Approves Amgen’s Lumakras for Lung Cancer Mutation
FDA Approves Amgen’s Lumakras for Lung Cancer Mutation

The U.S. Food and Drug Administration (FDA) has given Amgen’s Lumakras (sotorasib) accelerated approval as a treatment for patients diagnosed with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) - the first FDA approved treatment...

Fennec Pharmaceuticals Resubmits NDA for PEDMARK™
Fennec Pharmaceuticals Resubmits NDA for PEDMARK™

Fennec Pharmaceuticals has resubmitted their New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for PEDMARK™, a unique sodium thiosulfate formulation. PEDMARK is designed to prevent ototoxicity caused by cisplatin chemotherapy in patients under...